title: P-selectin blockade fails to improve acute lung injury in sheep.
abstract: Accumulation of neutrophils in the lung contributes to the endothelial damage in the tissue associated with acute respiratory distress syndrome. This initial recruitment of neutrophils within the pulmonary microvasculature may involve P-selectin. Thus we hypothesized that an antibody against P-selectin would reduce pulmonary damage. Sheep were chronically instrumented and prepared. The first group received 40% body surface area third-degree burns with 48 breaths of cotton smoke and 1 mg/kg of anti-(P-selectin) antibody (termed 3D4) 1 h post injury (n = 5). The second group (non-treated) received the same injury but no antibody treatment (n = 6). The third group comprised of sham animals without any injury or antibody treatment (n = 6). Sheep were studied for 48 h during which they were uniformly resuscitated with Ringer's lactate solution by following the Parkland formula. All the animals were mechanically ventilated. In the non-treated injured group, the arterial partial pressure of O(2) ('PaO(2)')/inspired fraction of O(2) ('F(i)O(2)') ratio dropped to 168+/-30 at 48 h, whereas the lung lymph flow increased to an average of 46+/-9 ml/h (10-fold of baseline). These changes were not prevented by an anti-(P-selectin) antibody. The plasma and lymph nitrate/nitrite levels were lower in the antibody-treated group than in the non-treated group. The lymph conjugated dienes were significantly lower in the treated animals. However, lung myeloperoxidase activity and lung tissue conjugated dienes were significantly increased in the treated animals compared with the non-treated injured controls. In conclusion, although the anti-(P-selectin) antibody did not protect against lung injury during the initial 48 h of burn and smoke, it decreased some aspects of injury in the peripheral microcirculation.
authors.affiliation: Department of Anesthesiology, The University of Texas Medical Branch and Shriners Burns Hospital, Galveston, TX 77555, USA.
authors.forename: Abhijit
authors.initials: A
authors.lastname: Chandra
authors.forename: Jiro
authors.initials: J
authors.lastname: Katahira
authors.forename: Frank C
authors.initials: FC
authors.lastname: Schmalstieg
authors.forename: Kazunori
authors.initials: K
authors.lastname: Murakami
authors.forename: Perenlei
authors.initials: P
authors.lastname: Enkhbaatar
authors.forename: Robert A
authors.initials: RA
authors.lastname: Cox
authors.forename: Hal K
authors.initials: HK
authors.lastname: Hawkins
authors.forename: Lillian D
authors.initials: LD
authors.lastname: Traber
authors.forename: David N
authors.initials: DN
authors.lastname: Herndon
authors.forename: Daniel L
authors.initials: DL
authors.lastname: Traber
mesh_terms: D000818:Animals; D000906:Antibodies / Q000627:therapeutic use*; D004195:Disease Models, Animal; D005260:Female; D006439:Hemodynamics; D007958:Leukocyte Count; D008196:Lymph / Q000378:metabolism; D010100:Oxygen / Q000097:blood; D010101:Oxygen Consumption; D019007:P-Selectin / Q000276:immunology*; D010313:Partial Pressure; D009195:Peroxidase / Q000378:metabolism; D011654:Pulmonary Edema / Q000517:prevention & control; D011659:Pulmonary Gas Exchange; D012128:Respiratory Distress Syndrome / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*; D012756:Sheep; D015208:Smoke Inhalation Injury / Q000150:complications / Q000503:physiopathology / Q000517:prevention & control*
chemical_list: D000906:Antibodies; D019007:P-Selectin; D009195:Peroxidase; D010100:Oxygen